Removing the black box warning for depot medroxyprogesterone acetate
Kaunitz, A.M.; Grimes, D.A.
Contraception 84(3): 212-213
2011
ISSN/ISBN: 1879-0518 PMID: 21843682 DOI: 10.1016/j.contraception.2011.01.009Document Number: 226202
Document emailed within 0-6 h
Related Documents
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Yang, L.; Hao, Y.; Hu, J.; Kelly, D.; Li, H.; Brown, S.; Tasker, C.; Roche, N.E.; Chang, T.L.; Pei, Z. 2019: Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women Emerging Microbes and Infections 8(1): 197-210
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Bakry, S.; Merhi, Z.O.; Scalise, T.J.; Mahmoud, M.S.; Fadiel, A.; Naftolin, F. 2008: Depot-medroxyprogesterone acetate: an update Archives of Gynecology and Obstetrics 278(1): 1-12
Bonhomme, M.G.; Potts, D.M.; Fortney, J.A.; Allen, M.Y. 1991: Safety of depot medroxyprogesterone acetate Lancet 338(8772): 942
Cromwell, P.; Anyan, W. 1998: Depot medroxyprogesterone acetate galactorrhea Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 23(2): 61
Mishell, D.R. 1996: Pharmacokinetics of depot medroxyprogesterone acetate contraception Journal of Reproductive Medicine 41(5 Suppl): 381-390
Cullins, V.E. 1996: Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate Journal of Reproductive Medicine 41(5 Suppl): 428-433
Atrio, J. 2015: Accounting for anovulation and vaginal thinning during depot medroxyprogesterone acetate use Journal of Infectious Diseases 211(5): 850
Guirguis-Blake, J. 2011: Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception American Family Physician 83(1): 35-36
Torok, M.R.; Miller, W.C.; Hobbs, M.M.; Macdonald, P.D.M.; Leone, P.A.; Schwebke, J.R.; Seña, A.C. 2009: The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis Sexually Transmitted Diseases 36(6): 336-340
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Arowojolu, A.O. 2000: Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience African Journal of Medicine and Medical Sciences 29(1): 55-58
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135